Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06577311RecruitingPhase 2
Light therapy for facial skin cancer (SCCis)
This study tests a light-activated treatment (photodynamic therapy) for a very early form of skin cancer on the face. It may offer an alternative to surgery.
Aventura, FloridaAges 18 years+ - NCT06577467Recruiting
Studying leftover virus after covid recovery
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
Bethesda, MarylandAges 18–110 - NCT06577844Recruiting
Video support for lung cancer surgery patients
This trial tests whether a video tool helps patients prepare for lung cancer surgery. It aims to improve understanding and reduce anxiety before and after the procedure.
MarseilleAges 18 years+ - NCT06577922Recruiting
Maternal and newborn health simulation lab study in Nepal
This trial checks whether simulation training for hospital staff improves care for mothers and newborns. If you recently delivered vaginally at a study hospital or work there, you may be able to join.
Kathmandu, BagmatiAges Any age - NCT06577896Recruiting
Onyx stent safety and effectiveness in older adults
This study looks at how well a specific brand of heart stent (Onyx) works in people 75 and older who have narrowed heart arteries. If you've already received an Onyx stent, the study will check its safety and effectiveness over time.
Yangsan, Gyeongsangnam-doAges 75–100 - NCT06578676RecruitingPhase 1
Testing two new drugs in healthy adults
This trial tests how two new drugs (HODO-22251 and HODO-22252) interact with each other and how safe they are in healthy adults. It helps doctors understand the best way to give these drugs together.
Daegu, Gyeongsangbuk-doAges 19 years+ - NCT06579417Recruiting
Testing a faster MRI for prostate cancer detection
This trial is testing a new, faster type of MRI scan (called biparametric MRI) to see if it can detect prostate cancer as well as the standard scan. It may help you avoid a longer scan and possibly reduce the need for contrast dye.
San Diego, CaliforniaAges 18 years+ - NCT06579469Recruiting
Study of later effects of CAR T cell therapy
This study follows children and young adults who received CAR T cell therapy to understand any long-term side effects that may appear months to years later. By joining, you help researchers learn how to better care for patients after this treatment.
Aurora, ColoradoAges Up to 30 years - NCT06579547Recruiting
Testing MRI instead of CT for joint imaging
This study tests if a new, radiation-free MRI method can replace standard CT scans for checking joint problems like arthritis. You would get both an MRI and a CT scan, and researchers compare the results to see if the MRI works just as well without radiation.
ZurichAges 18 years+ - NCT06579781Recruiting
Parent toolkit study for Georgia families with teens
This study tests a parent toolkit to support families with 12- to 15-year-olds. Families living together in certain Georgia areas may join to help improve communication and health.
Cairo, GeorgiaAges 12–15 - NCT06580418Recruiting
Study of an anti-TREM-1 drug in a gut model
This trial tests a new drug that blocks a protein called TREM-1, which may help reduce inflammation in the gut. It uses tissue samples from people with active ulcerative colitis or Crohn's disease to see if the drug is effective.
MilanAges 18–60 - NCT06581016Recruiting
Single-use vs. reusable scopes for stomach exams in the OR
This study compares single-use and reusable gastroscopes to see which works better during stomach exams done in the operating room. It may help you understand the tools used in your procedure.
KøgeAges 18 years+ - NCT06581419RecruitingPhase 1/Phase 2
Testing IAP0971 in advanced solid tumors and lung cancer
This trial tests a new drug called IAP0971 for people with advanced solid tumors or a specific type of lung cancer. It may help if your cancer has not responded to other treatments or if you have PD-L1-positive lung cancer that hasn't been treated yet.
Beijing, Beijing MunicipalityAges 18–75 - NCT06581562RecruitingPhase 1
Testing rituximab plus AB-101 for autoimmune diseases
This trial tests a new treatment (AB-101) combined with rituximab for people with certain autoimmune diseases like rheumatoid arthritis, pemphigus vulgaris, vasculitis, or lupus. It is for those who have not had success with standard therapies.
Plantation, FloridaAges 18 years+ - NCT06581770Recruiting
Turkish Digital Health Readiness Questionnaire Study
This study tests a Turkish version of a questionnaire about how ready people are to use digital health tools. It is for Turkish-speaking adults with chronic conditions like obesity, diabetes, heart disease, or lung disease.
Istanbul, IstanbulAges 18 years+ - NCT06582615Recruiting
MIND diet for better brain health during breast cancer treatment
This study tests whether a special diet (called the MIND diet) can help with thinking and memory in women being treated for triple negative breast cancer. Participants will receive nutrition coaching and support to see if it improves brain function.
New Haven, ConnecticutAges 40–65 - NCT06583993RecruitingEarly Phase 1
Gene Therapy for Advanced Bile Duct Cancer
This early-phase trial tests a new kind of gene therapy (called HNF4α srRNA) given through a vein for people with advanced intrahepatic cholangiocarcinoma, a type of liver cancer that has stopped responding to standard chemotherapy. The goal is to see if it is safe and if it can help slow or stop the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06585449RecruitingPhase 1
Study of ALN-HTT02 for Huntington's disease
This trial tests an experimental drug called ALN-HTT02 for people with Huntington's disease. The goal is to see if it can help manage symptoms. Participants must have stage 2 or early stage 3 Huntington's disease.
EdmontonAges 25–70 - NCT06586021Recruiting
Aortoseal device for sealing stent-grafts in belly aneurysms
This trial tests a new device called Aortoseal™ that is used during a stent-graft procedure to help secure the graft to the artery wall. It may improve the seal and help prevent the graft from slipping.
Norfolk, VirginiaAges 18 years+ - NCT06586905Recruiting
A study of a new syphilis test at an Ottawa sexual health clinic
This study tests a new rapid syphilis test (Multiplo® Complete Syphilis) that can be done at a clinic. It aims to see how well it detects infectious syphilis compared to standard lab tests. You might help if you are getting syphilis testing at the clinic.
Ottawa, OntarioAges 16 years+ - NCT06587529Recruiting
Preventing exploitation of kids: school program study
This study tests a curriculum called READY to Stand designed to prevent commercial sexual exploitation of children. It is for high school students in certain schools.
Des Moines, IowaAges 13–21 - NCT06588478RecruitingPhase 2
Study of pirtobrutinib for CLL or SLL
This trial tests a new drug called pirtobrutinib for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is for those whose cancer has come back or not responded to treatment, including a prior BTK inhibitor, and also for those who have never been treated but have a specific genetic change (17p deletion).
Chandler, ArizonaAges 18 years+ - NCT06588621Recruiting
Health of healthcare workers: a Paris hospital study
This trial studies the health of healthcare workers in training (residents) at seven Paris hospitals. It aims to evaluate their well-being through a short, anonymous survey.
Paris, IDFAges 18 years+ - NCT06590246RecruitingPhase 1/Phase 2
Study of C-CAR031 for advanced GPC3-positive liver cancer
This trial tests a new type of cell therapy called C-CAR031, which is designed to target and attack liver cancer cells that have a protein called GPC3. It is for people with advanced liver cancer who have already tried other treatments and are looking for a new option.
Shanghai, Shanghai MunicipalityAges 18–75
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,382 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.